Healthcare Goes Digital
Impetus Digital
We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result of this pandemic. At Impetus Digital, we believe all new, great ideas start with a conversation. Building on each other's ideas over time. One step at a time. This is how we believe positive disruption will occur. At Impetus Digital, we are leaders in delivering virtual collaboration experiences for life sciences companies. We offer the most comprehensive virtual meeting and event tools and services on the market. The Impetus InSite Platform® is a turn-key software solution that enables a “long-game” approach in connecting brands with key stakeholders, both synchronously and asynchronously. Its customizable, multilingual interface and its robust, pharma-compliant security make it the ideal choice for authentic engagement. Founded in 2008, we have over a decade of experience in virtualizing meetings and events. We offer a full range of strategic, medical writing, and digital services to help make the transition to hybrid events seamless. Visit our website www.impetusdigital.com to learn more!
Episodes
Mentioned books
Apr 21, 2020 • 9min
What Our Healthcare System Can Learn from AlphaGo
Machines have recently beat humans at games of strategy like chess and AlphaGo. With AlphaGo, there are more strategic moves than there are atoms in the universe. This says something profound about how machines, through neural networks and deep learning, can replicate the brilliance of the human mind.In this video, I discuss the possibility that machines can also learn the art and creativity behind the practice of medicine and to the eventual discovery of new medications and treatment and prevention paradigms for current enigmas associated with long-time chronic diseases such as cancer and diabetes.Machines may also be able to learn how to express empathy and intuitive thinking. This invites us to ask how machines may be able to go beyond human heuristics, automaticity, cultural memes, and biases. How can we leverage AI to manifest what was never conceived as being possible in medicine? In this podcast, I explore some of these possibilities.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalImpetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital
